NasdaqGM - Delayed Quote USD

BioHarvest Sciences Inc. (BHST)

6.29
+0.17
+(2.83%)
At close: May 23 at 4:00:00 PM EDT
Loading Chart for BHST
  • Previous Close 6.12
  • Open 6.17
  • Bid 6.56 x 100
  • Ask 6.75 x 100
  • Day's Range 6.12 - 6.38
  • 52 Week Range 0.00 - 7.38
  • Volume 10,027
  • Avg. Volume 23,344
  • Market Cap (intraday) 109.043M
  • Beta (5Y Monthly) 1.33
  • PE Ratio (TTM) --
  • EPS (TTM) -0.45
  • Earnings Date May 15, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 14.75

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and sale of science-based health and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada.

www.bioharvest.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: BHST

View More

Performance Overview: BHST

Trailing total returns as of 5/23/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

BHST
1.83%
S&P 500 (^GSPC)
1.34%

1-Year Return

BHST
3,396.11%
S&P 500 (^GSPC)
10.16%

3-Year Return

BHST
2,636.09%
S&P 500 (^GSPC)
46.03%

5-Year Return

BHST
2,734.68%
S&P 500 (^GSPC)
96.34%

Compare To: BHST

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BHST

View More

Valuation Measures

Annual
As of 5/23/2025
  • Market Cap

    109.04M

  • Enterprise Value

    122.73M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.88

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    4.43

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -51.27%

  • Return on Assets (ttm)

    -21.84%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    25.19M

  • Net Income Avi to Common (ttm)

    -12.91M

  • Diluted EPS (ttm)

    -0.45

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.39M

  • Total Debt/Equity (mrq)

    1,038.95%

  • Levered Free Cash Flow (ttm)

    -3.86M

Research Analysis: BHST

View More

Company Insights: BHST

Research Reports: BHST

View More

People Also Watch